University of Veterinary Medicine Vienna - Research portal

Diagrammed Link to Homepage University of Veterinary Medicine, Vienna

Selected Publication:

Open Access Logo

Type of publication: Journal Article
Type of document: Full Paper

Year: 2021

Authors: Weber, LA; Delarocque, J; Feige, K; Kietzmann, M; Kalbitz, J; Mei├čner, J; Paschke, R; Cavalleri, JV

Title: Effects of topically applied betulinic acid and nvx-207 on melanocytic tumors in 18 horses.

Source: Animals (Basel). 2021; 11(11):3250



Authors Vetmeduni Vienna:

Cavalleri Jessika-Maximiliane

Vetmed Research Units
University Equine Clinic, Clinical Unit of Equine Internal Medicine


Abstract:
The naturally occurring betulinic acid (BA) and its derivative NVX-207 induce apoptosis in equine melanoma cells in vitro. After topical application, high concentrations of the substances can be reached in healthy equine skin. With the aim to investigate the effect and safety of topically applied BA and NVX-207 in horses with melanocytic tumors, the longitudinal, prospective, randomized, double-blind, placebo-controlled study protocol included eighteen Lipizzaner mares with early-stage cutaneous melanoma assigned to three groups. Melanocytic lesions were topically treated either with a placebo, 1% BA or 1% NVX-207 twice a day for 91 days. Caliper measurements, clinical examinations and blood tests were performed to assess the effects and safety of the medication. The topical treatment was convenient and safe. The volumes of tumors treated with BA were significantly reduced over time as compared to tumors treated with the placebo from day 80 of the study. Although treatment with NVX-207 seemed to decrease tumor volume, these results did not reach statistical significance. The findings must be regarded as preliminary due to the limited group size and need to be replicated in a larger cohort with modified pharmaceutical test formulations. Accordingly, the treatment protocol cannot yet be recommended in its current form.


© University of Veterinary Medicine ViennaHelp and DownloadsAccessibility statement